This is the rapid fire Q&A section of the Patient from Hell podcast Episode 67: Surviving and Thriving: Janice's Metastatic Triple Negative Breast Cancer Story

Questions include:

What is a patient advocate?
What is MBC? (metastatic breast cancer)
What is TNBC? (triple negative breast cancer)
What's a lymph node?
What is Metavivor?
What's oligometastatic?
What's overall survival?
What's a recurrence rate?
What's distant recurrence?
What's local recurrence?
What is Scanxiety?
What's NED? (no evidence of disease)
What is SABCS? (San Antonio Breast Cancer Conference)
What's ASCO?
What's ADC? (antibody drug conjugate)
What is immunotherapy?
What are checkpoint inhibitors?
What's a CDK4/6?
What's median survival?
What is PFS? (progression free survival)
What is DFS? (disease free survival)

About our guest:

Diagnosed with Stage IV triple negative breast cancer in 2016, five years after an earlystage breast cancer diagnosis, Janice launched into patient advocacy following training through Living Beyond Breast Cancer’s (LBBC) Hear My Voice Outreach program in 2017. As a peertopeer support and research patient advocate, Janice is passionate about supporting others with metastatic breast cancer, in addition to continually furthering her scientific knowledge base of this disease, treatments, and clinical trials, which she acquires through attending scientific breast cancer conferences and webinars. Janice is involved with several patientfounded and led organizations including PCDI, GRASP, and Project Life MBC. As a trained peer support volunteer, she is founder of an international online peer support group for patients newly diagnosed with MBC. She serves on the Board of Directors for METAvivor Research and Support Inc., and is an Advisory Board member for Project Life MBC. She is an individual member of the Metastatic Breast Cancer Alliance. When she’s not busy with advocacy work, Janice enjoys traveling, reading, outdoor activities, and spending time with family, including her husband, two adult children and three grandchildren.
NOTE: There is one clarification from the rapid fire Q&A session. The definition of disease free survival (DFS) is the time from random assignment (used in clinical trials and research studies to assign participants to different groups) to cancer recurrence or death from any cause (Gutman SI, Piper M, Grant MD, et al. 2013).

Disclaimer: All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only. This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.